These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37492490)

  • 21. [Acute exacerbations of chronic obstructive pulmonary disease].
    Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
    Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of integrated pulmonary index to predict exacerbation of chronic obstructive pulmonary Disease's severity.
    Karaarslan FN; Öztürk ZS; Işık GÇ; Çevik Y
    Am J Emerg Med; 2023 Sep; 71():54-58. PubMed ID: 37331230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbations in Chronic Obstructive Pulmonary Disease: Identification and Prediction Using a Digital Health System.
    Shah SA; Velardo C; Farmer A; Tarassenko L
    J Med Internet Res; 2017 Mar; 19(3):e69. PubMed ID: 28270380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease.
    Crook S; Büsching G; Keusch S; Wieser S; Turk A; Frey M; Puhan MA; Frei A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2199-2206. PubMed ID: 30140152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colds as predictors of the onset and severity of COPD exacerbations.
    Johnston NW; Olsson M; Edsbäcker S; Gerhardsson de Verdier M; Gustafson P; McCrae C; Coyle PV; McIvor RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():839-848. PubMed ID: 28331305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the COPD Assessment Test respiratory item score on the decision to hospitalize patients with disease exacerbation in a hospital emergency department.
    Pulido Herrero E; Villanueva Etxebarria A; Aramburu Ojembarrena A; Piñera Salmerón P; Quintana López JM; Esteban González C; Gallardo Rebollal MS; Amigo Angulo JM; Urrutikoetxea Etxebarria S; Ibarrola Luengas I; Armentia Bardeci JM; García Gutiérrez S
    Emergencias; 2022 Apr; 34(2):95-102. PubMed ID: 35275459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
    Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
    PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bispectral index in hypercapnic encephalopathy associated with COPD exacerbation: a pilot study.
    Chalela R; Gallart L; Pascual-Guardia S; Sancho-Muñoz A; Gea J; Orozco-Levi M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2961. PubMed ID: 30310272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Exacerbation According to GOLD 2017 Categories in Patients with Chronic Obstructive Pulmonary Disease.
    Kim J; Lee CH; Lee MG; Shin KC; Yoo KH; Lim SY; Na JO; Yoo CG; Jung KS; Lee SD;
    Arch Bronconeumol (Engl Ed); 2019 Aug; 55(8):414-420. PubMed ID: 30922610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.
    Løkke A; Hilberg O; Lange P; Ibsen R; Stratelis G; de Fine Licht S; Lykkegaard J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():569-578. PubMed ID: 35321533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).
    Artaraz A; Crichton ML; Finch S; Abo-Leyah H; Goeminne P; Aliberti S; Fardon T; Chalmers JD
    Respir Res; 2020 Jan; 21(1):18. PubMed ID: 31931782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
    Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
    Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study.
    Oliveira CC; Lee AL; McGinley J; Anderson GP; Clark RA; Thompson M; Clarke S; Baker T; Irving LB; Denehy L
    COPD; 2017 Oct; 14(5):518-525. PubMed ID: 28745525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
    Crisafulli E; Sartori G; Huerta A; Gabarrús A; Fantin A; Soler N; Torres A
    Chest; 2023 Dec; 164(6):1422-1433. PubMed ID: 37516272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
    Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.
    Sprooten RTM; Rohde GGU; Lawyer G; Leijte WT; Wouters EFM; Franssen FME
    Respirology; 2019 Aug; 24(8):765-776. PubMed ID: 30897284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.